Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.28K Sell
186
-148
-44% -$5.5K ﹤0.01% 1716
2026
Q1
$13.7K Buy
334
+224
+204% +$10.6K ﹤0.01% 1347
2025
Q4
$5.11K Sell
110
-1
-0.9% -$46 ﹤0.01% 1770
2025
Q3
$5.2K Buy
111
+105
+1,750% +$5.03K ﹤0.01% 1705
2025
Q2
$292 Buy
+6
New +$261 ﹤0.01% 932

Other funds holding QGEN

Salomon & Ludwin's QGEN Position: Q2 2026 in Review

Salomon & Ludwin reduced its Qiagen (QGEN) stake by 44% in Q2 2026, selling an estimated $5.5K and leaving 186 shares worth $7.28K. The position accounts for ﹤0.01% of the portfolio, ranked #1716.

Salomon & Ludwin first reported a position in QGEN in Q2 2025 and has held it in 5 quarters since. The position peaked at $13.7K in Q1 2026. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • Salomon & Ludwin held 186 shares of Qiagen worth $7.28K as of Q2 2026.
  • Salomon & Ludwin sold 148 Qiagen shares in Q2 2026, an estimated $5.5K.
  • Qiagen made up ﹤0.01% of Salomon & Ludwin's portfolio in Q2 2026, its #1716 holding.
  • Salomon & Ludwin first reported a position in Qiagen in Q2 2025 and has held it in 5 quarters since.
  • Salomon & Ludwin's Qiagen position peaked at $13.7K in Q1 2026.
  • 336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.